Skip to main content
. 2019 Apr 26;52(1):10–23. doi: 10.4143/crt.2019.145

Table 1.

Correlation between CTSC expression and patients’ clinicopathological factors

Variable CTSC expression
p-value
No. (n=122) High (n=62) Low (n=60)
Age (yr)
 ≤ 50 56 29 27 0.884
 > 50 66 33 33
Sex
 Female 13 8 5 0.413
 Male 109 54 55
HBsAg
 Negative 14 6 8 0.526
 Positive 108 56 52
Cirrhosis
 Absent 27 9 18 0.039
 Present 95 53 42
Ascites
 Absent 106 49 57 0.009
 Present 16 13 3
AFP (μg/L)
 < 400 56 21 35 0.005
 ≥ 400 65 41 24
Tumor size (cm)
 ≤ 5 46 25 21 0.544
 > 5 76 37 39
No. of tumors
 Solitary 80 43 37 0.372
 Multiple 42 19 23
Tumor capsule
 Complete 73 33 40 0.130
 Incomplete 49 29 20
PVTT
 Absent 96 49 47 0.925
 Present 26 13 13
Differentiation
 Ⅰ-Ⅱ 101 49 52 0.264
 Ⅲ-Ⅳ 21 13 8

CTSC, cathepsin C; HBsAg, hepatitis B virus surface antigen; AFP, α-fetoprotein; PVTT, portal vein tumor thrombus.